SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-000370
Filing Date
2019-01-03
Accepted
2019-01-03 16:02:27
Documents
3
Period of Report
2018-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv510197_8k.htm 8-K 33637
2 EXHIBIT 10.1 tv510197_ex10-1.htm EX-10.1 54217
3 EXHIBIT 99.1 tv510197_ex99-1.htm EX-99.1 13058
  Complete submission text file 0001144204-19-000370.txt   102421
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 19505307
SIC: 2834 Pharmaceutical Preparations